Jan 27
Current report
8-K
Charter or bylaw amendment, or fiscal year change
ONSS · ONASSIS HOLDINGS CORP.
Market Cap
$25,582
Shares
127.91M
Volume · Sep 24
100
Avg daily vol (4 sessions)
625
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
Available close range$0.00–0.00
Avg vol 30d16K
Short int2K · 0.0% of shares · 5.5d
Short vol100%
DataJan 2020–Sep 2026
The closing range uses available history since Feb 17, 2026; less than a full year is stored.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−100%
below
Price vs 50-day avg
−97%
below
RSI (14)
38
neutral
MACD trend
Positive
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−92%
trailing
6-month return
−98%
trailing
YTD return
+50%
this year
Relative strength
−115%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 5.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
101549%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
500.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−100%
Bearish
Price vs 50-day avg
−97%
Bearish
RSI (14)
38
Neutral
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 5.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $0
Now $0 · 100%
Range high $0
vs 200-day avg -100%
vs 50-day avg -97%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ONSS
this stock
ONASSIS HOLDINGS CORP.
|
$25,582 | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$67.48B | +35.5% | — | — | 0.1% |
|
GALDY
Galderma Group AG
|
$54.01B | +11.7% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$50.93B | +39.9% | +4.3% | 99.2 | 2.4% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
$40.66B | — | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ONSS | +50.0% | -91.7% | -97.5% | +0.0% | +50.0% |
| SPY | +0.6% | +0.1% | +17.0% | +0.0% | +12.5% |
| vs SPY | +49.4% | -91.8% | -114.5% | 0.0% | +37.5% |